Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06665620 · ClinicalTrials.gov registry record · NA
Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
A NA study of Suicide and Anhedonia, sponsored by Ksana Health.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06665620: Active NA study of Suicide and Anhedonia, sponsored by Ksana Health.
NCT06665620 is a NA study of Suicide and Anhedonia that is active but no longer recruiting, run by Ksana Health. The registered enrollment target is 20 participants, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06665620, a NA study of Suicide and Anhedonia, is active but no longer recruiting, sponsored by Ksana Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide safety planning. The BRITE suicide safety planning app was developed on evidence-based principles and has undergone rigorous formative development and effectiveness evaluations. However, to optimize its functionality, commercial viability, and scale its implementation, issues related to user engagement need to be addressed. This 4-week Micro-Randomized Trial (MRT) will optimize specific components of ViraBrite, an augmented version of the BRITE suicide safety planning app that integrates automated algorithms (i.e., just in time adaptive intervention features) to facilitate increased engagement with coping skills and pushes safety planning materials to users at periods of high risk (i.e., increases in emotional distress).
Primary Outcome
Engagement with the ViraBrite app (i.e., tapping on the push notification, patterns of accessing app features such as coping skills and safety plan) between the current and next randomization
Conditions Studied
Interventions
- BEHAVIORAL ViraBrite nudges
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-16 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
What the registry record for NCT06665620 still lists
NCT06665620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which ViraBrite nudges is the first listed.
NCT06665620 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06665620 about?
NCT06665620 is a clinical study titled "Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents". Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide...
What is the current status of trial NCT06665620?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-16. Estimated completion is 2026-02-01.
What conditions does trial NCT06665620 study?
This clinical trial studies the following conditions: Suicide, Anhedonia, Mental Health Disorder.
What interventions are being tested in trial NCT06665620?
The interventions under investigation include: ViraBrite nudges (BEHAVIORAL).
Who is sponsoring clinical trial NCT06665620?
This trial is sponsored by Ksana Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06665620 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06665620's enrollment target sits among peer trials
20 88th of 92 higher than 5 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI